| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
1981-10-29^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1984-03-27^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_108d076a51e2c75d1f7480ff04c8912f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8be4d680d9d2735dc1c9be2a2ff834c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4cbb0fe7d20819895fe2765c1881d87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_639f14218f5baa55aff9cd93737e05f7 |
| publicationDate |
1984-03-27^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-1164459-A |
| titleOfInvention |
Process for preparing (imidazo¬1,2-a|pyridine- 2-yl)-carbostyril or -3,4-dihydrocarbostyryl derivatives |
| abstract |
0-02-26677C/Kt(PG-846)/81 ABSTRACT A carbostyril compouud of the formula (I) (I) wherein the values of the substituents are as defined in the description, and pharmaceutically acceptable salts thereof, composition containing the compound of the formula (I) or its pharmaceutically acceptable salt as an active ingredient, and process for prcparing same. The compound of the formula (I) and its pharmaceutically acceptable salts have cardiotonic effects. |
| priorityDate |
1980-11-11^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |